Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4LRF

Phosphopentomutase S154G variant soaked with ribose 5-phosphate

4LRF の概要
エントリーDOI10.2210/pdb4lrf/pdb
関連するPDBエントリー3M8Z 3TWZ 3TX0 3UN3 4LR7 4LR8 4LR9 4LRA 4LRB 4LRC 4LRD 4LRE
分子名称Phosphopentomutase, MANGANESE (II) ION, GLYCEROL, ... (5 entities in total)
機能のキーワードalkaline phosphatase family, isomerase
由来する生物種Bacillus cereus
タンパク質・核酸の鎖数3
化学式量合計140654.71
構造登録者
Birmingham, W.A.,Starbird, C.A.,Panosian, T.D.,Nannemann, D.P.,Iverson, T.M.,Bachmann, B.O. (登録日: 2013-07-19, 公開日: 2013-07-31, 最終更新日: 2024-11-06)
主引用文献Birmingham, W.R.,Starbird, C.A.,Panosian, T.D.,Nannemann, D.P.,Iverson, T.M.,Bachmann, B.O.
Bioretrosynthetic construction of a didanosine biosynthetic pathway.
Nat.Chem.Biol., 10:392-399, 2014
Cited by
PubMed Abstract: Concatenation of engineered biocatalysts into multistep pathways markedly increases their utility, but the development of generalizable assembly methods remains a major challenge. Herein we evaluate 'bioretrosynthesis', which is an application of the retrograde evolution hypothesis, for biosynthetic pathway construction. To test bioretrosynthesis, we engineered a pathway for synthesis of the antiretroviral nucleoside analog didanosine (2',3'-dideoxyinosine). Applying both directed evolution- and structure-based approaches, we began pathway construction with a retro-extension from an engineered purine nucleoside phosphorylase and evolved 1,5-phosphopentomutase to accept the substrate 2,3-dideoxyribose 5-phosphate with a 700-fold change in substrate selectivity and threefold increased turnover in cell lysate. A subsequent retrograde pathway extension, via ribokinase engineering, resulted in a didanosine pathway with a 9,500-fold change in nucleoside production selectivity and 50-fold increase in didanosine production. Unexpectedly, the result of this bioretrosynthetic step was not a retro-extension from phosphopentomutase but rather the discovery of a fortuitous pathway-shortening bypass via the engineered ribokinase.
PubMed: 24657930
DOI: 10.1038/nchembio.1494
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2 Å)
構造検証レポート
Validation report summary of 4lrf
検証レポート(詳細版)ダウンロードをダウンロード

239149

件を2025-07-23に公開中

PDB statisticsPDBj update infoContact PDBjnumon